Lipe & Dalton bought a new stake in The Clorox Company (NYSE:CLX – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 5,925 shares of the company’s stock, valued at approximately $565,000.
Other institutional investors and hedge funds have also modified their holdings of the company. Darwin Wealth Management LLC bought a new position in Clorox in the second quarter valued at approximately $29,000. Caitlin John LLC raised its position in shares of Clorox by 1,807.1% during the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after acquiring an additional 253 shares during the last quarter. Ancora Advisors LLC acquired a new position in shares of Clorox in the 2nd quarter valued at $28,000. Avalon Trust Co acquired a new position in shares of Clorox in the 2nd quarter valued at $29,000. Finally, Markowski Investments bought a new position in shares of Clorox in the 2nd quarter worth $30,000. 78.53% of the stock is owned by institutional investors.
Clorox Trading Down 1.5%
Shares of Clorox stock traded down $1.37 during trading hours on Tuesday, hitting $91.69. The company’s stock had a trading volume of 2,754,307 shares, compared to its average volume of 2,597,211. The Clorox Company has a 12 month low of $84.70 and a 12 month high of $128.90. The stock has a 50 day moving average of $99.81 and a 200 day moving average of $101.34. The company has a market capitalization of $11.09 billion, a PE ratio of 19.02, a price-to-earnings-growth ratio of 2.91 and a beta of 0.56. The company has a debt-to-equity ratio of 15.80, a current ratio of 0.66 and a quick ratio of 0.38.
Clorox Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, August 28th. Shareholders of record on Wednesday, August 12th were paid a $1.25 dividend. The ex-dividend date of this dividend was Wednesday, August 12th. This is an increase from Clorox’s previous quarterly dividend of $1.24. This represents a $5.00 dividend on an annualized basis and a yield of 5.5%. Clorox’s payout ratio is presently 103.73%.
Analysts Set New Price Targets
A number of equities research analysts recently commented on the company. Deutsche Bank Aktiengesellschaft set a $98.00 price objective on Clorox in a report on Tuesday, August 4th. Wall Street Zen cut Clorox from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. Citigroup increased their price target on shares of Clorox from $97.00 to $100.00 and gave the company a “neutral” rating in a research report on Tuesday, August 4th. BNP Paribas Exane reduced their price objective on shares of Clorox from $97.00 to $95.00 and set a “neutral” rating on the stock in a research note on Monday, July 20th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Clorox in a report on Friday, July 10th. Twelve investment analysts have rated the stock with a Hold rating and five have issued a Sell rating to the stock. According to data from MarketBeat, Clorox has an average rating of “Reduce” and an average target price of $102.40.
View Our Latest Analysis on CLX
Clorox Company Profile
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Recommended Stories
- Five stocks we like better than Clorox
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
